Synthetic modified messenger RNA for therapeutic applications
- 13 June 2021
- journal article
- review article
- Published by Elsevier BV in Acta Biomaterialia
- Vol. 131, 1-15
- https://doi.org/10.1016/j.actbio.2021.06.020
Abstract
No abstract availableKeywords
Funding Information
- Fundamental Research Funds for the Central Universities
- Startup Foundation for Hundred-Talent Program of Zhejiang University
- National Natural Science Foundation of China
- Ministry of Science and Technology of the People's Republic of China
This publication has 201 references indexed in Scilit:
- Combinational Targeting Offsets Antigen Escape and Enhances Effector Functions of Adoptively Transferred T Cells in GlioblastomaMolecular Therapy, 2013
- Genetic engineering of human pluripotent cells using TALE nucleasesNature Biotechnology, 2011
- Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated PatientsMolecular Therapy, 2011
- Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5Nature Immunology, 2011
- A Short Pulse of IL-4 Delivered by DCs Electroporated With Modified mRNA Can Both Prevent and Treat Autoimmune Diabetes in NOD MiceMolecular Therapy, 2010
- Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNACell Stem Cell, 2010
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological StabilityMolecular Therapy, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- An improved zinc-finger nuclease architecture for highly specific genome editingNature Biotechnology, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006